Merck KGa A's generics business
GPTKB entity
Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:business
|
| gptkbp:aims_to |
reduce healthcare costs
|
| gptkbp:collaborates_with |
healthcare organizations
|
| gptkbp:competes_with |
other generic manufacturers
|
| gptkbp:develops |
new generic formulations
|
| gptkbp:employs |
thousands of people
|
| gptkbp:expansion |
emerging markets
|
| gptkbp:focuses_on |
generic pharmaceuticals
|
| gptkbp:founded_in |
gptkb:2014
|
| gptkbp:has_part |
sales department
marketing team quality assurance team R& D department |
| https://www.w3.org/2000/01/rdf-schema#label |
Merck KGa A's generics business
|
| gptkbp:is_active_in |
digital health solutions
social responsibility programs |
| gptkbp:is_committed_to |
sustainability
|
| gptkbp:is_engaged_in |
gptkb:market_research
community outreach clinical research |
| gptkbp:is_focused_on |
patient safety
therapeutic areas patient access |
| gptkbp:is_involved_in |
gptkb:supply_chain_management
patient education regulatory compliance patient advocacy partnerships with NGOs pharmaceutical education |
| gptkbp:is_known_for |
gptkb:customer_service
ethical practices affordable medications high-quality generics |
| gptkbp:is_linked_to |
global health initiatives
healthcare innovation |
| gptkbp:is_located_in |
gptkb:Germany
|
| gptkbp:is_part_of |
gptkb:Merck_Group
global supply chain global healthcare system Merck's corporate strategy |
| gptkbp:is_recognized_for |
innovation
|
| gptkbp:is_regulated_by |
gptkb:FDA
|
| gptkbp:is_supported_by |
gptkb:government_policies
gptkb:investors |
| gptkbp:offers |
generic drugs
|
| gptkbp:operates_in |
gptkb:pharmaceuticals
|
| gptkbp:part_of |
gptkb:Merck_KGa_A
|
| gptkbp:participates_in |
clinical trials
|
| gptkbp:revenue |
€1 billion
|
| gptkbp:targets |
healthcare providers
|
| gptkbp:utilizes |
advanced manufacturing techniques
|
| gptkbp:bfsParent |
gptkb:Mylan
gptkb:Lupin_Pharmaceuticals |
| gptkbp:bfsLayer |
5
|